Beyond Cardiometabolic Risk: A Multi-Organ Analysis of Cardiac, Pulmonary, and Gastrointestinal Manifestations in Metabolic Syndrome
1Babar Zaman, 1Javed Akhtar, 2Adnan Raja, 3Dr Mohammad Masood Khoso, 1Qazi Zamir Ali, 2Ali Raza
1Dow University, Karachi
2Agha Khan Hospital, Karachi
3Assistant Professor Gastroenterology Jinnah Sindh Medical University Karachi.
Vol: 16-02
Received: January 25, 2026 Accepted: March 02, 2026 Published: July 06, 2026
Abstract
Background: Metabolic syndrome (MetS) is a cluster of metabolic abnormalities—including insulin resistance, visceral obesity, dyslipidemia, and hypertension—traditionally evaluated through a cardiovascular lens. However, emerging clinical evidence suggests that the systemic chronic inflammatory and microvascular changes associated with MetS extend far beyond traditional cardiovascular boundaries, driving pathology in the respiratory and digestive systems. Objectives: This cross-specialty review aims to comprehensively delineate the multisystemic impact of MetS, focusing on the pathophysiological interplay and clinical consequences across the cardiac, pulmonary, and gastrointestinal (GI) systems. Methods: A search of major databases (PubMed/MEDLINE, Embase, and Web of Science) was conducted to synthesize current literature detailing the manifestations of MetS. We analyzed the shared pathways linking metabolic dysfunction to specific organ comorbidities, focusing on cardiac remodeling, respiratory mechanics, and digestive/hepatic pathologies. Results: Systemic low-grade inflammation, oxidative stress, and ectopic fat deposition act as common drivers of multi-organ damage. Cardiac: MetS accelerates coronary artery disease, left ventricular hypertrophy, and diastolic dysfunction, significantly elevating the risk of heart failure with preserved ejection fraction (HFpEF). Pulmonary: Adipokine dysregulation and mechanical restriction impair ventilatory function, directly exacerbating obstructive sleep apnea (OSA), asthma, and obesity hypoventilation syndrome. Gastrointestinal: MetS is intrinsically linked to metabolic dysfunction-associated steatotic liver disease (MASLD/MASH) and dysbiosis of the gut microbiota, which further drives systemic endotoxemia and increases the risk of colorectal and gastroesophageal malignancies. Conclusion: MetS is a highly complex, multisystem disorder that transcends traditional disciplinary boundaries. Optimizing patient outcomes requires a transition from fragmented, organ-specific care to an integrated, cross-specialty clinical approach involving cardiologists, pulmonologists, and gastroenterologists to mitigate the synergistic burden of these interlinked complications.Keywords: Metabolic Syndrome; Cardiovascular Disease; Obstructive Sleep Apnea; MASLD; Dysbiosis; Cross-Specialty Medicine